| Date | Title | Description |
| 17.10.2024 | C-STAR Appoints Industry Icon Mitch Presnick as Chief Advisor | NEW YORK, Oct. 17, 2024 /PRNewswire/ -- C-STAR, a tech-empowered real estate investment company, is pleased to announce the appointment of Mitch Presnick as Chief Advisor. A seasoned investor and entrepreneur with over three decades of expe... |
| 11.10.2024 | The Rise of Trade Associations and the Fight Against Junk Fees | In the world of business, trade associations are like lighthouses in a storm. They guide industries through turbulent waters, advocating for their members and shaping policy. The International Franchise Association (IFA) has emerged as a be... |
| 11.10.2024 | The International Franchise Association Tops the 2024 Trade Association Rankings — Here's What It's Doing Right The findings are part of APCO's 10th annual TradeMarks study, which surveyed over 330 co... | Trade associations saw a resurgence in perceived effectiveness in 2024 — bouncing back after two years of decline — and the International Franchise Association (IFA) was among the standout performers. It gained recognition for its efforts i... |
| 07.10.2024 | /C O R R E C T I O N -- APAC Liver Disease Alliance/ | In the news release, APAC LIVER DISEASE ALLIANCE HOSTS "HEP-FREE: ELIMINATING ASIA'S SILENT PUBLIC HEALTH THREAT BY 2030" SUMMIT IN BANGKOK ON 1 OCTOBER 2024, issued 02-Oct-2024 by APAC Liver Disease Alliance over PR Newswire, we ... |
| 02.10.2024 | APAC LIVER DISEASE ALLIANCE HOSTS "HEP-FREE: ELIMINATING ASIA'S SILENT PUBLIC HEALTH THREAT BY 2030" SUMMIT IN BANGKOK ON 1 OCTOBER 2024 | BANGKOK, Oct. 2, 2024 /PRNewswire/ -- The APAC Liver Disease Alliance, in collaboration with Thailand's Department of Disease Control, Ministry of Public Health, kicks off the Alliance's inaugural "Hep-Free: Eliminating Asia's Silent P... |
| 02.08.2024 | NEW STUDY FINDS OVER 60 CASES OF ASSISTED SUICIDE IN PATIENTS WITH EATING DISORDERS, WITH LITTLE OVERSIGHT | WASHINGTON, Aug. 2, 2024 /PRNewswire/ -- A groundbreaking study published today in Frontiers in Psychiatry reveals that over sixty individuals with eating disorders have undergone assisted death in Belgium, the Netherlands, and the United S... |
| 11.07.2024 | Though Headwinds Mount, ALM Pacesetter Research Finds that ESG's Social Component Continues to Figure in Client Business Strategies | ALM
A new report on the "S" of ESG finds that Innovators are helping clients confront the complexities of ESG in business, helping address risk while also supporting fundamental value creation and long-term business strategy
NEW Y... |
| 17.06.2024 | Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund | - Funds to support the advancement of SF001, a next-generation polyene antifungal designed for reduced toxicity
NEW YORK, June 17, 2024 /PRNewswire/ -- Elion Therapeutics ("Elion", formerly Sfunga Therapeutics), a biotechnology co... |
| 05.06.2024 | Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development | Frank Nestle, MD, FMedSci joins Deerfield from previous position as Global Head of Research and Chief Scientific Officer at Sanofi
Nestle will lead therapeutic discovery and development as Partner and Chief Executive Officer of Deerfield Di... |
| 21.05.2024 | ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance treatment through two years for adults with moderately to severely active Crohn's disease and ulcerative ... | Findings from the extended LIBERTY studies and associated post-hoc analysis support the long-term efficacy and safety of ZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab[1],[2]
Data from a post-hoc analysis of the LIBERTY... |
| 17.05.2024 | Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference | Data presentations including the extended LIBERTY studies to highlight the long-term treatment goals of ZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab
The data underscores Celltrion's commitment to improving patient out... |
| 17.05.2024 | Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference | Data presentations including the extended LIBERTY studies to highlight the long-term treatment goals of ZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab
The data underscores Celltrion's commitment to improving patient out... |
| 10.05.2024 | Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition cost | Adalimumab-aaty will be priced at an 85% discount to HUMIRA® (adalimumab)
Branded and unbranded versions of Celltrion USA's adalimumab biosimilar help provide more affordable options for patients
JERSEY CITY, N.J., May 10, 2024 /PRNewswire/... |
| 09.05.2024 | Dr. Chelsea Clinton, Danny Wirtz, and Valerie Jarrett to Headline Social Innovation Summit on June 4-5 in Chicago | Two-day event will feature timely sessions on mental health, LGBTQIA+, youth empowerment, reproductive rights, and more
NEW YORK, May 9, 2024 /PRNewswire/ -- Today, Social Innovation Summit (SIS) announced the initial two-day agenda for the... |
| 09.05.2024 | Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition cost | Adalimumab-aaty will be priced at an 85% discount to HUMIRA® (adalimumab)
Branded and unbranded versions of Celltrion USA's adalimumab biosimilar help provide more affordable options for patients
JERSEY CITY, N.J., May 9, 2024 /PRNewswire/ ... |
| 09.05.2024 | Thousands set to gather in Singapore for Rotary's international convention, the Garden City's largest association event post-pandemic | SINGAPORE, May 9, 2024 /PRNewswire/ -- More than 13,000 Rotary members and participants from over 120 countries will gather in Singapore from 25 to 29 May 2024 for the membership service organisation's annual gathering.
2011 Nobel Peace Lau... |
| 08.05.2024 | HTL Biotechnology Acquires Modern Meadow's Human Recombinant Collagen Platform | HTL Biotechnology, a global leader in biopolymers, makes a strategic move by acquiring Modern Meadow's beauty and biomedical division, including the advanced human recombinant collagen platform. This acquisition propels HTL Biotechnology in... |
| 07.05.2024 | HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow's human recombinant collagen platform for beauty and biomedical applications | JAVENÉ, France, May 6, 2024 /PRNewswire/ -- HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American comp... |
| 06.05.2024 | HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow's human recombinant collagen platform for beauty and biomedical applications | JAVENÉ, France, May 6, 2024 /PRNewswire/ -- HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American comp... |
| 28.04.2024 | Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including the first FDA-approved subcutaneous infliximab ZYMFENTRA™ | JERSEY CITY, N.J., April 28, 2024 /PRNewswire/ -- Celltrion USA announced today that it has signed an agreement with Express Scripts, one of the nation's leading pharmacy benefit managers (PBMs) negotiating on behalf of health plans coverin... |
| 08.01.2024 | Asia-Pacific Data Centre Association Launches as Voice of Data Centre Operators in the Region | New Delhi, Delhi, India
APDCA founding members represent eight key players in the global data centre industry, including AirTrunk, Digital Realty, Equinix, Global Switch, NTT Global Data Centers, Princeton Digital Group, ST Telemedia Global... |
| 30.11.2023 | Climate Change is Top Global Concern, Public Expects Transparency on Climate Action, APCO Survey Finds | New Delhi, Delhi, India
Climate change is the biggest emergency for people around the world, but they are divided on how to address it, according to APCO Worldwide’s inaugural global Climate Action Confidence Tracker, conducted in partnersh... |
| 08.11.2023 | APCO Launches Adaptive Intelligence, AI Advisory Offering to Help Companies Navigate Business Transformation | New Delhi, Delhi, India
As businesses around the globe act to understand and capitalize on the full potential of artificial intelligence, APCO Worldwide announced today that it is launching a new form of adaptive intelligence called Margy—a... |
| 08.11.2023 | APCO Launches Adaptive Intelligence, AI Advisory Offering to Help Companies Navigate Business Transformation | APCO's newest AI-powered team member, Margy, will provide real-time insights, trend forecasting, content generation and other skills by fusing adaptive intelligence with the collective wisdom of its powerful team
SINGAPORE, Nov. 8, 2023 /PR... |
| 21.04.2023 | Partners for a Zero Emission Vehicle Future Applauds Maryland Clean Truck Act | Amendments to Advanced Clean Truck Regulation Provide Confidence to Fleets, Owners and Operators
WASHINGTON, April 21, 2023 /PRNewswire/ -- As states continue to pursue air quality and climate goals, the Partners for a Zero Emission Vehicle... |
| 30.11.2022 | Economic conditions are hurting healthcare workers mentally and physically | Still, a majority said they would take less pay for more flexible hours
The vast majority of workers don't feel like they're paid enough, with only around one-third believing that their pay is equitable. This has a number of different conse... |
| 28.11.2022 | Double Rainbow Announces World's First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications | Lexington, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- DoubleRainbow Biosciences ("Double Rainbow"), a sustainable biotech company harnessing bioengineering to improve the quality of human health, today announced the world's first co... |
| 24.10.2022 | Pretium, Progress Residential Provide Single-Family Rental Housing for Forest Cove Families in Partnership with Atlanta Mayor Andre Dickens | Pretium's Senior Managing Director Jocelyn Moore Delivers Prepared Remarks Alongside Mayor Dickens
Remarks as Prepared for Delivery
ATLANTA, Oct. 24, 2022 /PRNewswire/ -- Good morning. Thank you, Mayor Dickens, for your leadership on afford... |
| 05.08.2022 | Fire Safety Experts Discuss Ways of 'Building a Fire Safe India' | New Delhi, Delhi, India
The Accidental Deaths and Suicides in India (ADSI) reports maintained by National Crime Records Bureau shows that fire accidents in India have, on an average, killed 35 people a day in the five years between 2016 and... |
| 22.12.2021 | Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker "HYPR" on the Nasdaq Global Market | GUILFORD, Conn., Dec. 22, 2021 /PRNewswire/ -- Hyperfine Inc., the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it has completed its business combination... |
| 16.12.2021 | Hyperfine and the Brain Tumor Foundation Launch National Partnership to Increase Access to Early Brain Tumor Detection | GUILFORD, Conn., Dec. 16, 2021 /PRNewswire/ -- Hyperfine, Inc., the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, and the Brain Tumor Foundation have launched a new partnershi... |
| 13.12.2021 | Hyperfine Appoints New Board of Directors | GUILFORD, Conn., Dec. 13, 2021 /PRNewswire/ -- Hyperfine Inc., creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging™ (MRI) device, today announced the Board of Directors that will serve subsequent to the closing of t... |
| 09.12.2021 | Hyperfine Announces Expansion into Canadian Market with Medical Device License Issued by Health Canada | GUILFORD, Conn., Dec. 9, 2021 /PRNewswire/ -- Hyperfine, Inc., creator of the first FDA-cleared portable magnetic resonance imaging™ (MRI) device, Swoop®, today announced the Health Canada licensing of Swoop as well as the commercial launch... |
| 07.12.2021 | Hyperfine Partners With Madonna's Charitable Organization, Raising Malawi, to Increase Access to High Quality Healthcare for Children | GUILFORD, Conn., Dec. 7, 2021 /PRNewswire/ -- Hyperfine Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device™, Swoop®, today announced a partnership with Raising Malawi, which built and co-operates Malawi'... |
| 29.11.2021 | Hyperfine Receives FDA Clearance for Deep Learning Portable MRI, Defining the Future of Life-Saving Diagnostics | GUILFORD, Conn., Nov. 29, 2021 /PRNewswire/ -- Hyperfine, Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop®, today announced the FDA 510(k) clearance and launch of its new advanced image reconst... |
| 02.11.2021 | Hyperfine Announces Receipt of Additional $3.3 Million Grant to Improve Access to Neonatal and Pediatric Brain Imaging in Low-Resource Settings Globally | GUILFORD, Conn., Nov. 2, 2021 /PRNewswire/ -- Hyperfine, Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop®, today announced it received an additional $3.3 million grant from the Bill & Melin... |
| 28.10.2021 | Hyperfine Appoints Scott White as Chief Commercial Officer | GUILFORD, Conn., Oct. 28, 2021 /PRNewswire/ -- Hyperfine, Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop®, today announced the appointment of Scott White as chief commercial officer. With deep... |
| 22.09.2021 | Most Business Executives Would Be Willing To Pay Cyber Ransoms: New Survey | Fuel tanks are seen at Colonial Pipeline Baltimore Delivery in Baltimore, Maryland on May 10, 2021. ... [+] - The US government declared a regional emergency Son May 9, 2021 as the largest fuel pipeline system in the United States remained ... |
| 08.09.2021 | Eirion Therapeutics Announces Strategic Agreement for HTL Biotechnology to Become Eirion's Exclusive Botulinum API Manufacturer | WOBURN, Mass. and JAVENÉ, France, Sept. 8, 2021 /PRNewswire/ -- Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced that HTL Biotechnology, the worldwide leader in biotechnolo... |
| 30.06.2021 | APCO Worldwide : Italy MD Paolo Compostella Named Europe Region President | New Chief Innovation Officer, Europe COO and Managing Director, London Also Named
London - June 30, 2021:Paolo Compostella, managing director of APCO Worldwide's Italy offices and 15-year veteran at the firm, was named president, Europe, AP... |
| 21.03.2021 | UAE’s University of Wollongong in Dubai to Give Students Looking for International Degrees ‘The Edge’ in the Global Pursuit for Future-Ready Skills | TEL AVIV, Israel & DUBAI, United Arab Emirates--(BUSINESS WIRE)--Mar 21, 2021--
The United Arab Emirates (UAE) continues to pioneer new approaches to attract professional excellence, expertise, and talent from around the world. The coun... |
| 11.03.2021 | Global Immunization Possible by 2022 With Fair Vaccine Distribution, Says WHO COVID-19 Special Envoy | DUBAI, United Arab Emirates--(BUSINESS WIRE)--Mar 11, 2021--
The World Government Summit Dialogues saw world leaders outline solutions to humanity’s most urgent challenges during the virtual event on 9-10 March.
This press release features ... |
| 10.12.2020 | Contura Closes Transaction Divesting Cumberland Mine | |
| 18.03.2019 | The policy initiatives Scott Gottlieb championed at the FDA will remain after he departs | The resignation of Scott Gottlieb as commissioner of the Food and Drug Administration raises a big question: Will the policies so publicly advocated by Gottlieb continue after his departure?
Gottlieb has been one of the most communications-... |
| 18.09.2017 | Inside the MPAA, Netflix & Amazon Global Anti-Piracy Alliance | The idea of collaboration in the anti-piracy arena isn’t new but an announcement this summer heralded what is destined to become the largest project the entertainment industry has ever seen.
The Alliance for Creativity and Entertainment (AC... |
| - | Eight in Ten Americans Working From Home Due to COVID-19 Say They Miss In-person Meetings and Conventions | WASHINGTON--(BUSINESS WIRE)--Mar 1, 2021--
A new survey by APCO Insight affirms that Americans working from home are eager to return to in-person meetings and conventions. The survey finds that even after adapting to the new digital workpla... |
| - | ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance treatment through two years for adults with moderately to severely active Crohn's disease and ulcerative ... | Findings from the extended LIBERTY studies and associated post-hoc analysis support the long-term efficacy and safety of ZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab[1],[2]
Data from a post-hoc analysis of the LIBERTY... |
